LONG BEACH, Calif.--(Business Wire)--
Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and
therapeutic skin health systems, announced today that Company management will
present a corporate overview at the following two investor conferences:
* The 11th Annual ICR XChange Conference to be held on January 14-15, 2009 at
the St. Regis Monarch Beach Resort in Dana Point, Calif. The presentation will
take place at 8:50 am (PST) on Wednesday, January 14, 2009.
* The 27th Annual JP Morgan Healthcare Conference to be held on January 12-15,
2009 at the Westin St. Francis in San Francisco, Calif. The presentation will
take place at 12:30 pm (PST) on Thursday, January 15, 2009.
A live webcast of the JP Morgan presentation will be available via the Internet
by visiting the investor relations section of the Company's web site at
www.obagi.com. The archived presentation will be available on the web site for
30 days.
About Obagi Medical Products, Inc.
Obagi Medical Products develops and commercializes skin health products for the
dermatology, plastic surgery, and related aesthetic markets. Using its
Penetrating Therapeutic technologies, Obagi Medical's products are designed to
improve penetration of agents across the skin barrier for common and visible
skin conditions in adult skin including chloasma, melasma, senile lentigines,
acne vulgaris and sun damage. The history of Obagi's skin care product
introductions is as follows: Obagi Nu-Derm, 1988; Obagi-C Rx (the first and only
prescription-strength vitamin C and hydroquinone system), 2004; Obagi
Professional-C (a line of highly stable vitamin C serums), 2005; Obagi Condition
and Enhance for use with cosmetic procedures to enhance patient outcomes and
satisfaction, 2006; Obagi ELASTIderm eye treatment and Obagi CLENZIderm M.D.
acne therapeutic systems, 2007; a formulation of Obagi CLENZIderm M.D. Systems
for normal to dry skin, June 2007; Obagi ELASTIderm Décolletage System, January
2008 and SoluCLENZ Rx Gel for the pharmacy channel in August 2008. Visit
www.obagi.com for information.
Investor Contact:
Obagi Medical Products, Inc.
Preston Romm
CFO, EVP of Finance, Operations & Administration, 562-628-1007
or
ICR, Inc.
Ina McGuinness/Lena Adams, 310-954-1100
Copyright Business Wire 2009
